Development of Antifouling and Bactericidal Coatings for Platelet Storage Bags Using Dopamine Chemistry
Source abstract
Abstract
Abstract Platelets have a limited shelf life, due to the risk of bacterial contamination and platelet quality loss. Most platelet storage bags are made of a mixture of polyvinyl chloride with a plasticizer, denoted as pPVC. To improve biocompatibility of pPVC with platelets and to inhibit bacterial biofilm formation, an antifouling polymer coating is developed using mussel‐inspired chemistry. A copolymer of N,N‐dimethylacrylamide and N‐(3‐aminopropyl)methacrylamide hydrochloride is synthesized and coupled with catechol groups, named DA51‐cat. Under mild aqueous conditions, pPVC is first equilibrated with an anchoring polydopamine layer, followed by a DA51‐cat layer. Measurements show this coating decreases fibrinogen adsorption to 5% of the control surfaces. One‐step coating with DA51‐cat does not coat pPVC efficiently although it is sufficient for coating silicon wafers and gold substrates. The dual layer coating on platelet bags resists bacterial biofilm formation and considerably decreases platelet adhesion. A cationic antimicrobial peptide, E6, is conjugated to DA51‐cat then coated on silicon wafers and introduces bactericidal activity to these surfaces. Time‐of‐flight second ion‐mass spectroscopy is successfully applied to characterize these surfaces. pPVC is widely used in medical devices; this method provides an approach to controlling biofouling and bacterial growth on it without elaborate surface modification procedures.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Polymer Surface Interaction Studies · Antimicrobial agents and applications · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Center for Blood Research University of British Columbia 2350 Health Sciences Mall Vancouver V6T 1Z3 Canada
Department of Chemistry University of British Columbia Vancouver V6T 1Z1 Canada
Institute of Chemistry and Biochemistry Freie Universität Berlin Takustrasse 3 14195 Berlin Germany
Department of Pathology and Laboratory Medicine University of British Columbia Vancouver V6T 2B5 Canada
Funding
Natural Sciences and Engineering Research Council of Canada
References (64)
Show source-provided references
1. 10.1046/j.1365-2141.2003.04468.x10.1046/j.1365-2141.2003.04468.x ↗
2. 10.1111/j.1423-0410.2008.01042.x10.1111/j.1423-0410.2008.01042.x ↗
3. 10.1016/B978-1-78242-105-4.00001-810.1016/B978-1-78242-105-4.00001-8 ↗
4. 10.1016/j.biomaterials.2008.12.04110.1016/j.biomaterials.2008.12.041 ↗
5. 10.1016/j.smim.2016.04.00610.1016/j.smim.2016.04.006 ↗
6. 10.1016/j.biomaterials.2004.01.02310.1016/j.biomaterials.2004.01.023 ↗
7. 10.1016/j.polymer.2010.08.02210.1016/j.polymer.2010.08.022 ↗
8. 10.1002/adma.20100121510.1002/adma.201001215 ↗
9. 10.1039/c2cs35170f10.1039/c2cs35170f ↗
10. 10.1016/S1468-6996(00)00012-710.1016/S1468-6996(00)00012-7 ↗
11. 10.1002/ange.20140054610.1002/ange.201400546 ↗
12. 10.1002/anie.20140054610.1002/anie.201400546 ↗
13. 10.1016/j.cll.2010.02.00210.1016/j.cll.2010.02.002 ↗
14. 10.1067/mlc.2001.11648610.1067/mlc.2001.116486 ↗
15. 10.1002/mabi.20100022310.1002/mabi.201000223 ↗
16. 10.1016/S0142-9612(01)00017-510.1016/S0142-9612(01)00017-5 ↗
17. 10.1016/S0142-9612(02)00515-X10.1016/S0142-9612(02)00515-X ↗
18. 10.1099/jmm.0.071449-010.1099/jmm.0.071449-0 ↗
19. 10.1111/j.1423-0410.2008.01051.x10.1111/j.1423-0410.2008.01051.x ↗
20. 10.1002/adhm.20160117310.1002/adhm.201601173 ↗
21. 10.1002/adhm.20150070010.1002/adhm.201500700 ↗
22. 10.1039/C4TB00550C10.1039/C4TB00550C ↗
23. 10.1016/j.bcp.2016.09.01810.1016/j.bcp.2016.09.018 ↗
24. 10.1586/14787210.5.6.95110.1586/14787210.5.6.951 ↗
25. 10.1016/j.bbamem.2006.11.01010.1016/j.bbamem.2006.11.010 ↗
26. 10.1111/voxs.1201310.1111/voxs.12013 ↗
27. 10.1111/trf.1217310.1111/trf.12173 ↗
28. 10.1111/j.1537-2995.2012.03708.x10.1111/j.1537-2995.2012.03708.x ↗
29. 10.1126/science.114724110.1126/science.1147241 ↗
30. 10.1146/annurev-matsci-062910-10042910.1146/annurev-matsci-062910-100429 ↗
31. 10.1039/C5PY01234A10.1039/C5PY01234A ↗
32. 10.1016/j.actbio.2016.05.03510.1016/j.actbio.2016.05.035 ↗
33. 10.1246/cl.2012.165510.1246/cl.2012.1655 ↗
34. Wei Q. · Angew. Chem. · 2014 · 126 · 1183410.1002/ange.201407113 ↗
35. 10.1002/anie.20140711310.1002/anie.201407113 ↗
36. 10.1002/adma.20130473710.1002/adma.201304737 ↗
37. 10.1021/la048626g10.1021/la048626g ↗
38. 10.1002/mabi.20130022410.1002/mabi.201300224 ↗
39. 10.1002/adfm.20120017710.1002/adfm.201200177 ↗
40. 10.1021/am500362k10.1021/am500362k ↗
41. 10.1073/pnas.131501511010.1073/pnas.1315015110 ↗
42. 10.1021/la204831b10.1021/la204831b ↗
43. 10.1021/bc200053410.1021/bc2000534 ↗
44. 10.1016/j.colsurfb.2010.01.01410.1016/j.colsurfb.2010.01.014 ↗
45. 10.1093/infdis/167.2.31210.1093/infdis/167.2.312 ↗
46. 10.1021/am200978h10.1021/am200978h ↗
47. 10.1021/la200620s10.1021/la200620s ↗
48. 10.2217/nnm.11.7610.2217/nnm.11.76 ↗
49. 10.1021/nn404117j10.1021/nn404117j ↗
50. 10.1021/am402386310.1021/am4023863 ↗
51. 10.1002/adma.20090140710.1002/adma.200901407 ↗
52. 10.1007/s00277-009-0762-210.1007/s00277-009-0762-2 ↗
53. 10.1086/52914310.1086/529143 ↗
54. 10.1038/nrmicro82110.1038/nrmicro821 ↗
55. 10.1038/nbt0403-36110.1038/nbt0403-361 ↗
56. 10.1111/j.1541-4337.2003.tb00012.x10.1111/j.1541-4337.2003.tb00012.x ↗
57. 10.1111/trf.1375610.1111/trf.13756 ↗
58. 10.22203/eCM.v008a0510.22203/eCM.v008a05 ↗
59. 10.1021/am302763510.1021/am3027635 ↗
60. 10.1002/adfm.20120115610.1002/adfm.201201156 ↗
61. 10.1021/la001209t10.1021/la001209t ↗
62. The cost of a platelet unit produced by the apheresis method is estimated to be approximately 500 USD. We estimate the cost of our double layer modification to be less than 7% of this which encourages the development of such coatings for improving the quality safety and possibly longevity of platelets.
63. Ulman A. · 1991
64. 10.1021/cr00014a00610.1021/cr00014a006 ↗